CSF2 and glioblastoma: We compared the transcriptome (scRNA-seq) of patient-derived GBM cells after 3 days’ exposure to CSF or GM to determine the single-cell molecular identity, as defined by Neftel et al. (34) (Fig. 4 and fig.